All Stories

  1. Phenological and Morphological Characterization of Watermelon (Citrullus lanatus L.) Subjected to Spiritual Blessing/Biofield Energy Treatment (SBET)
  2. The Trivedi Effect® (Blessing/Biofield Energy Treatment): A Novel Approach to Boosting Muskmelon (Cucumis melo) Crop Development and Harvest Yield
  3. Effects of Spiritual Blessing Energy Treatment (SBET) on the growth and yield of Momordica charantia (bitter gourd)
  4. Evaluating the Effects of Blessing/Biofield Energy Interventions (BEI) on Eggplant’s (Solanum melongena L.) Growth, Development, and Productivity
  5. Morphological Attributes and Yield of Momordica charantia (Bitter Gourd) Under the Application of Spiritual Blessing/Biofield Energy Treatment (BET)
  6. Spiritual Blessing Energy Treatment as an Approach for Boosting Growth and Yield of Bottle Gourd (Lagenaria siceraria L.)
  7. Modulation of Summer Squash Growth and Productivity Via Spiritual Blessings (Biofield) Energy Treatment (SBET)
  8. The Role of Spiritual Blessing Energy Treatment in Optimizing Radish (Raphanus sativus L.). Growth and Crop Yield
  9. Effectiveness of Distant/Remote Blessing Treatment on Cognitive-motor Function: A Randomized Double-blind Placebo-controlled Trial
  10. Exploring the Therapeutic Potentials of Nonpharmacological Blessing Energy Intervention for the Benefits of Psycho-Mental Impaired Individuals: A Clinical Trial
  11. Impact of Biofield Energy Treatment on Broiler Chicken Growth Performance, Feed Efficiency, Carcass Characteristics, and Meat Quality
  12. Growth, Production Performance, and Meat Quality Assessment of Broiler Chickens Using an Alternative, Affordable Biofield Energy Treatment Strategy
  13. Assessment of cognitive–motor functions in adults with perceived neuropsychological problems using NIH toolbox after remote biofield energy treatment as non‐pharmacological intervention: A randomized double‐blind placebo controlled trial
  14. Effects of distant biofield energy healing on adults associated with psychological and mental health-related symptoms: a randomized, placebo-controlled, double-blind study
  15. The use of biofield energy therapy as complementary and alternative medicine in human health care system: a narrative review and potential mechanisms
  16. Quantum Biofield Energy Therapy for Psychological and Mental Health Problems
  17. Cannabidiol (CBD) Upregulates Vitamin D3 Receptors (VDRs) Expression That Modulates Cytokines (TNF-α, IL-6), Tissue Elasticity, Cellular Senescence, and Mitochondrial ATP Generation in Human and Rodent Cell Lines
  18. Vitamin D3 Supplementation: Improving Memory, Muscle Function, and Pain in Deficient Rats
  19. Simultaneous identification and quantification of pentacyclic triterpenoids and phenolic compounds from the leaves of Boswellia serrata using LC–MS/MS tandem mass spectrometry
  20. Efficacy of a novel proprietary dietary supplement (TRI 360TM) on psychological symptoms and stress-related quality of life in adult subjects: A randomized controlled clinical trial
  21. Impact on Fundamental Physiological Functional Biomarkers after Administration of Biofield Treated Formulation in Unpredictable Chronic Stress (UCS)-Induced Rats
  22. Evaluation of Anti-inflammatory Activity after Treatment with the Biofield Energy Treated Proprietary Test Formulation on Combination of Cecal Slurry, LPS and E. Coli Induced Systemic Inflammatory Response Syndrome (SIRS) in Sprague Dawley Rats
  23. Evaluation of Inflammatory Serum Cytokines after Treatment with the Consciousness Energy Healing Based Proprietary Test Formulation on Combination of Cecal Slurry, LPS and E. Coli Induced Systemic Inflammatory Response Syndrome (SIRS) in Sprague Dawley...
  24. Antioxidant and Anti-Inflammatory Activities of Biofield Energy Treated Proprietary Test Formulation in Brain Tissues in Cecal Slurry, LPS and E. Coli-Induced Systemic Inflammatory Response Syndrome (SIRS) in Sprague Dawley Rats
  25. Evaluation of Cardiac Performance after Treatment with the Biofield Energy Treated Proprietary Test Formulation on L-NAME and High Fat Diet-Induced Cardiovascular Disorders in Sprague Dawley Rats
  26. Evaluation of Antioxidative Potential of the Biofield Energy Treated Proprietary Test Formulation on L-NAME and High Fat Diet-Induced Cardiovascular Disorders in Sprague Dawley Rats
  27. Elasticity Profile of Skin, Neuronal, Cardiac, and Skeletal Muscle Cells after Treatment with the Biofield Energy Healing-Based Proprietary Test Formulation
  28. Oxidative Stress and Inflammatory Biomarkers Analysis of Biofield Treated Proprietary Test Formulation in Heart Tissues in Cecal Slurry, LPS and E. Coli-induced Systemic Inflammatory Response Syndrome (SIRS) in Sprague Dawley Rats
  29. Anti-Inflammatory Activity of Biofield Energy Treated Proprietary Test Formulation on Cecal Slurry, LPS and E. coli Induced Systemic Inflammatory Response Syndrome (SIRS) Model in Sprague Dawley Rats
  30. Evaluation of Immunomodulatory Effect of a Novel Test Formulation in D-Galactose-Induced Aging Dysfunction in Sprague Dawley Rats
  31. Antioxidant and Anti-Inflammatory Activities of Biofield Energy Treated Proprietary Test Formulation in Intestinal Tissues on Combination of Cecal Slurry, LPS and E. coli Induced Systemic Inflammatory Response Syndrome (SIRS) in Sprague Dawley Rats
  32. Evaluation of Renal and Cardioprotective Potential of the Biofield Energy Treated Proprietary Test Formulation on L-NAME and High Fat Diet-Induced Cardiovascular Disorders in Sprague Dawley Rats
  33. LC-MS and GC-MS-Based Assessment of the Impact of Consciousness Energy Healing Treatment on the Isotopic Abundance Ratios of Sulfamethoxazole
  34. Structural Characterization and Isotopic Abundance Ratio Analysis of the Consciousness Energy Healing Treated Ofloxacin
  35. Effect of Biofield Treatment on Blood, Hepatic, and Cardiac Biomarkers in Vitamin D3 Deficiency Diet (VDD) Induced Sprague Dawley Rats
  36. Characterization of the Consciousness Energy Healing Treated Cholecalciferol Using LC-MS and GC-MS Spectrometry
  37. Study of the Consciousness Energy Healing Treatment and It’s Effect on the Isotopic Abundance Ratio of Ascorbic Acid (Vitamin C)
  38. Evaluation of the Isotopic Abundance Ratio of Consciousness Energy Healing Treated L-Tryptophan Using LC-MS Spectrometry
  39. Effect of Consciousness Energy Healing Treatment on the Metal Profile and Properties of Tellurium
  40. Antioxidant Activity of Biofield Treated Proprietary Test Formulation Supplemented with Vitamins and Minerals in Vitamin D3 Deficiency Diet (VDD) Induced Sprague Dawley Rats
  41. Evaluation of Vitamin D3 metabolite (25-OH Vit D3), Neurotransmitter (ACh), and the Expression of Proinflammatory Cytokines (IL-6 and TNF-α) in Tissue Homogenate after Administration of Biofield Energy Healing-based Novel Proprietary Test Formulation a...
  42. Liquid Chromatography-Mass Spectrometry Based Isotopic Abundance Ratio Analysis of the Consciousness Energy Healing Treated L-Cysteine
  43. "A Comprehensive Study of Isotopic Abundance Ratio Analysis of the Consciousness Energy Healing Treated Berberine Chloride Using LC-MS and GC-MS"
  44. sotopic Abundance Ratio Evaluation of the Consciousness Energy Treated Pyridoxine Using LC-MS and GC-MS Spectrometry
  45. "Impact of Consciousness Energy Healing Treatment on the Isotopic Abundance Ratio of Folic Acid"
  46. Evaluation of the Impact of Consciousness Energy Healing Treatment on the Isotopic Abundance Ratio of L-Cysteine Using LC-MS Spectrometry
  47. Evaluation of the Impact of Consciousness Energy Healing Treatment on the Isotopic Abundance Ratio of Folic Acid Using LC-MS Spectrometry
  48. Influence of Consciousness Energy Healing Treatment on the Isotopic Abundance Ratio of Sulfamethoxazole Using LC-MS and GC-MS Spectrometry
  49. Impact of Biofield Energy Healing Treatment on the Isotopic Abundance Ratio Analysis of Pyridoxine HCl Using LC-MS and GC-MS Spectrometry
  50. Identification of Endothelin-1 and Nitric Oxide Activity in Aorta, Lung and Kidney after Treatment with the Biofield Energy Treated Proprietary Test Formulation on L-Name and High Fat Diet-Induced Cardiovascular Disorders in Sprague Dawley Rats
  51. Evaluation of Inflammatory Response after Treatment with the Biofield Energy Treated Proprietary Test Formulation on Combination of Cecal Slurry, LPS and E. coli Induced Systemic Inflammatory Response Syndrome (SIRS) in Sprague Dawley Rats
  52. Neuroprotective (iNOS), fibrinolytic (FDP) Markers Analysis of Biofield Treated Proprietary Test Formulation on Cecal Slurry, LPS and E. coli Induced Systemic Inflammatory Response Syndrome (SIRS) Model in Sprague Dawley Rats
  53. Evaluation of Inflammatory Serum Biomarkers after Treatment with the Consciousness Energy Healing-Based Proprietary Test Formulation on L-NAME and High Fat Diet-Induced Cardiovascular Disorders in Sprague Dawley Rats
  54. Study of VDR Expression after Treatment with the Biofield Energy Healing-Based Proprietary Test Formulation Using Cellular Models
  55. Estimation of Sex Hormone, Blood Profiling, and Histopathological Analysis after Treatment with the Biofield Energy Treated Proprietary Test Formulation in Unpredictable Chronic Stress (UCS)- Induced Sprague Dawley Rats
  56. Study of Behavioral Parameters in Vitamin D3 Deficiency Diet (VDD) Induced Animal Model: An Influence of Biofield Energy Healing Treatment
  57. Impact of Consciousness Energy Healing Treatment on the Isotopic Abundance Ratio of Sulfamethoxazole Using LC-MS and GC-MS Spectrometry
  58. The LC-MS and GC-MS Based Isotopic Abundance Ratio Analysis of the Consciousness Energy Healing Treated Silver Sulfadiazine
  59. Isotopic Abundance Ratio Analysis of the Consciousness Energy Healing Treated Flutamide using LC-MS and GC-MS Spectrometry
  60. Evaluation of Cardiac Biomarkers after Administration of the Biofield Energy Treated Proprietary Test Formulation on L-NAME and High Fat Diet-Induced Cardiovascular Disorders in Sprague Dawley Rats
  61. Evaluation of Stress Biomakers (Cytokines) in Presence of Unpredictable Chronic Stress (UCS) in Sprague Dawley Rats after Treatment with the Biofield Energy Treated Novel Proprietary Test Formulation
  62. Effects of Consciousness Energy Healing Treatment on the Improvement of Relative Oral Bioavailability of Low Bioavailable Resveratrol in Male Sprague Dawley Rats
  63. The Isotopic Abundance Ratio of Consciousness Energy Treated L-Tryptophan Using LC-MS Spectrometry
  64. Influence of the Biofield Energy Treatment on the Pharmacokinetics of 25-Hydroxyvitamin D3 in Male Sprague-Dawley Rats after a Single Oral Dose of Vitamin D3
  65. The Biofield Energy Treatment and its Effect on the Relative Oral Bioavailability of Lovastatin Hydroxy Acid in Rats after a Single Oral Dose of Lovastatin
  66. Antioxidant and Anti-Inflammatory Activities of Biofield Energy Treated Proprietary Test Formulation in Lungs Tissues on Combination of Cecal Slurry, LPS and E. coli Induced Systemic Inflammatory Response Syndrome (SIRS) in Sprague Dawley Rats
  67. LC-MS and GC-MS Based Isotopic Abundance Ratio Analysis of Consciousness Energy Healing Treated Ofloxacin
  68. Analysis of Isotopic Abundance Ratio of Consciousness Energy Healing Treated Metronidazole Using LC-MS and GC-MS Spectrometry
  69. Assessment of Neurobehavioral and Anti-Aging Effect of the Test Formulation in D-Galactose-Induced aging Dysfunction in Sprague Dawley Rats
  70. Prevention of Aging and Improvement of Longevity and Life-Span in D-Galactose Induced Aging Rats After Treatment with the Biofield Energy Per Se and Biofield Treated Proprietary Test Formulation
  71. Gas Chromatography and Mass Spectroscopy (GC-MS) Based Isotopic Abundance Ratio Evaluation of the Biofield Energy Treated Metronidazole
  72. Effect of the Biofield Energy Treated Proprietary Test Formulation for Sleep Biomarkers in the Unpredictable Chronic Stress (UCS) Animal Model
  73. Antiaging, Cognition and Anti-Inflammatory Potential of the Biofield Energy Treatment in Vitamin D3 Deficiency Diet (VDD) Induced Sprague Dawley Rats
  74. Impact of Consciousness Energy Healing Treatment on the Isotopic Abundance Ratio of Cefazolin Sodium Using LC-MS and GC-MS Spectrometry
  75. Improvement of Vitamin D 3 Metabolites Level after Oral Administration of the Biofield Energy Treated Proprietary Test Formulation in Vitamin D 3 Deficiency Diet (VDD) Induced Rat Model
  76. Evaluation of the Impact of Consciousness Energy Healing Treatment on the Isotopic Abundance Ratios (PM+1/PM and PM+2/PM) of Ofloxacin
  77. Influence of Consciousness Energy Healing Treatment on the Properties of Polylactic-co- Glycolic Acid (PLGA)
  78. Characterization of the biofield energy treated aluminium using PSA, PXRD, and TGA/DTG analytical techniques
  79. Consciousness Energy Healing Treatment Influenced the Physicochemical Properties of Zinc
  80. "Evaluation of Physicochemical and Thermal Properties of the Consciousness Energy Healing Treated Tellurium"
  81. In Vitro Cell-Based Biomarkers Study of Vital Organs: Impact of the Biofield Energy Based Test Formulation
  82. Impact of Biofield Energy Treatment Based Test Formulation on Vital Organ Health Specific Biomarkers Using Cell Line Study
  83. Cell-Based Vital Organs Specific Biomarkers Assessment using Biofield Energy Based Novel Test Formulation
  84. Antioxidant and Organ Protective Potential of the Consciousness Energy Healing-Based Novel Test Formulation Using Different Biomarkers Analysis
  85. "Assessment of the Biofield Energy Healing Based Test Formulation on Human Organ Health Specific Biomarkers In Vitro Assays"
  86. Powder X-ray Diffraction and Particle Size Analysis of the Consciousness Energy Healing Treated Vanadium Pentoxide (V2O5)
  87. Consciousness Energy Healing Treatment: Impact on Physicochemical and Thermal Properties of Zinc
  88. Consciousness Energy Healing Treatment: Physicochemical and Thermal Characterization of Magnesium
  89. Consciousness Energy Healing Treatment: Impact on the Physicochemical and Thermal Properties of Pyridoxine HCl
  90. Complementary and Alternative Medicine: Impact of Consciousness Healing Treatment on the Characteristic Properties of Sulfamethoxazole
  91. Physicochemical and Thermal Characterization of Ascorbic Acid: Impact of Biofield Energy Treatment
  92. Physicochemical and Thermal Characterization of the Consciousness Energy Healing Treated Folic acid
  93. Evaluation of Stress Biomarkers after Oral Administration of the Consciousness Energy Healing Treated Novel Herbomineral Formulation in Male Sprague Dawley Rats
  94. Solid State Characterization of the Consciousness Energy Healing Treated Magnesium
  95. Evaluation of the Physicochemical and Thermal Properties of Consciousness Energy Healing Treated Cefazolin Sodium
  96. Evaluation of a Consciousness Energy Healing Based Test Formulation for Skin Health
  97. Complementary and Alternative Medicine: Evaluation of the Physicochemical and Thermal Properties of the Biofield Energy Treated Metronidazole
  98. Solid State Characterization for a Comparative Evaluation of the Biofield Energy Treated and Un-treated Ascorbic Acid
  99. Evaluation of the Physicochemical and Thermal Properties of Folic Acid: Influence of the Energy of Consciousness Healing Treatment
  100. Evaluation of Estrogenic Activity of Biofield Energy Treatment for the Potential of Menstrual Disorders Using Ishikawa Cell Line
  101. Flutamide: Impact of Consciousness Energy Healing Treatment on the Physicochemical and Thermal Characteristics
  102. Complementary and Alternative Medicine: Evaluation of the impact of Biofield Energy Treatment on L-Cysteine
  103. Spectroscopic and Calorimetric Evaluation of the Biofield Energy Healing Treated Ofloxacin
  104. Effect of the Consciousness Energy Healing Treatment on the Characteristic Properties of Cefazolin Sodium
  105. Complementary and Alternative Medicine: Impact of Consciousness Energy Healing Treatment on the Cholecalciferol (Vitamin D3)
  106. Biofield Energy Treatment: Physicochemical and Thermal Characterization of L-Tryptophan
  107. Consciousness Energy Healing Treatment: Spectroscopic and Calorimetric Evaluation of the Biofield Energy Treated Hydroxypropyl β-Cyclodextrin
  108. Anti-Rheumatoid Arthritis (RA) Action of Biofield Energy Treatment Using Synovial Sarcoma Cell Line (SW982)
  109. Assessment of Anti-Ageing Potential of Consciousness Energy Healing Treated DMEM and HFF-1 Cells using Cellular Proliferation and Collagen Metabolism Assays
  110. Characterization of the Physicochemical and Thermal properties of the Biofield Energy Treated Flutamide Using PSA, PXRD, TGA/DTG, and DSC Analytical Techniques
  111. Particle Size, Surface Area, Crystallite Size, and Thermal Analysis of Consciousness Energy Healing Treated Selenium
  112. Assessment of the Physicochemical and Thermal Characterization of Biofield Energy Treated Polylactic-co-glycolic acid (PLGA)
  113. Complementary and Alternative Medicine: Impact of Biofield Energy Treatment on the Physicochemical and Thermal Properties of Withania somnifera Root Extract
  114. Biofield Energy Treatment Based Test Formulation as a Novel and Efficient Approach on Various Biomarkers in human Bones, Heart, Liver, Lungs, and Brain Cells
  115. Investigation of Vital Organ Specific Biomarkers Using CellBased Assays after Treatment with the Biofield Energy Treated Test Formulation
  116. Study of the Effect of Consciousness Energy Healing Treatment on the Natural Product Berberine Chloride
  117. Evaluation of the Outcome of Consciousness Energy Healing Treatment on the Physicochemical and Thermal Properties of Magnesium
  118. Impact of the Trivedi Effect® on the Physicochemical Properties of Antimony
  119. Impact of Consciousness Energy Healing Treatment on the Physicochemical and Thermal Properties of an Anticancer Drug 6-Mercaptopurine
  120. Biofield Energy Therapy: Role in Multiple Organ Health Specific Biomarkers in Cell-Based Assay
  121. Physicochemical and Thermal Characterization of Consciousness Energy Healing Treated Copper (II) Chloride Using PXRD, DSC, and TGA/DTG
  122. Powder XRD, PSD and DSC Analysis of the Consciousness Energy Healing Treated Zinc Chloride
  123. Evaluation of the Effect of Consciousness Energy Healing Treatment on the Physicochemical and Thermal Properties of Silver Oxide
  124. Consciousness Energy Healing Treatment: Impact on Physicochemical and Thermal Properties of Silver Sulfadiazine
  125. Wound Healing Activity of Consciousness Energy Healing Treatmenton HFF-1 Cells and DMEM Using Scratch Assay
  126. Evaluation of the Consciousness Energy Healing Treated Berberine Chloride Using PXRD, PSA, and DSC Analysis
  127. Complementary and Alternative Medicine: Impact of Consciousness Energy Healing Treatment on the Physicochemical and Thermal Properties of 6-Mercaptopurine
  128. The Physicochemical and Thermal Properties of Consciousness Energy Healing Treated Silver Oxide (Ag2O)a
  129. In Vitro Assessment of Biofield Energy Healing Treatment on Hair Growth by Enhanced Proliferation of Human Follicular Dermal Papilla Cells (HFDPCs)
  130. In vitro Assessment of Biofield Energy Treated DMEM on Thermogenesis Using Myoblasts Cell Line (C2C12)
  131. Assessment of Biofield Energy Treatment on Liver Health Using Hepatocellular Carcinoma Cell Line (HepG2)
  132. Influence of the Biofield Energy Therapy on the Physicochemical and Thermal Properties of Sulfamethoxazole
  133. Assessment of the Influence of Biofield Energy Treatment on the Physicochemical and Thermal Properties of Lead Using PXRD, PSA, and DSC
  134. Evaluation of the Physicochemical and Thermal Properties of Chromium Trioxide (CrO3): Impact of Consciousness Energy Healing Treatment
  135. Consciousness Energy Healing Treatment: Impact on the Physicochemical and Thermal Characteristics of Folic Acid
  136. Effect of Consciousness Energy Healing Treatment on the Physicochemical and Thermal Properties of Selenium
  137. An Investigation of the Consciousness Energy Healing Therapy on Physicochemical and Thermal Properties of Silver Sulfadiazine
  138. Antioxidative Potential of Consciousness Energy Healing Treatment on HepG2 Cells and DMEM after Oxidative Stress Induced by Hydrogen Peroxide
  139. Impact of Consciousness Energy Healing Treatment on the Physicochemical and Thermal Properties of Silver Oxide
  140. Effect of the Consciousness Energy Healing Treatment on DMEM for the Proliferation and Differentiation of Human Bone Osteosarcoma Cells to Improve Bone Health
  141. Antiaging Potentia
  142. Evaluation of the Physicochemical and Thermal Properties of the Biofield Energy Healing Treated Ofloxacin
  143. Antiaging Potential of Consciousness Energy Healing-Based Novel Proprietary Formulation
  144. Role of Vitamin D3 on Bone Health in Human Bone Osteosarcoma Cells (MG-63): Influence of Biofield Energy Healing Treatment
  145. Impact of Consciousness Energy Healing Treatment on the Physicochemical and Thermal Properties of Vitamin D3 (Cholecalciferol)
  146. The Effect of Consciousness Energy Healing Treatment on the Physicochemical and Thermal Properties of L-Cysteine
  147. The Effect of Consciousness Energy Healing Treatment on Physicochemical and Thermal Properties of 6-Mercaptopurine
  148. Consciousness Energy Healing Treatment on the Physicochemical and Thermal Properties of Selenium
  149. Evaluation of the Physicochemical and Thermal Properties of Consciousness Energy Healing Treated Lead Using PXRD, PSA, and DSC Analysis
  150. Assessment of Biofield Energy Healing Based Vitamin D3 Effects on Bone Health Parameters
  151. Biofield Energy Treated Vitamin D3 on the Structural Crosslinks, Maturation, and Bone Mineralization
  152. Assessment of Energy of Consciousness Healing on Cell Growth of Plant Stem Cells Callus Culture
  153. "A Comparative Analysis of Vitamin D3 and Biofield Energy Treated Vitamin D3 in Bone Health Using MG-63 Cell Line"
  154. Increase in Bone Mass Density and Overall Bone Health Following High-Impact of Bio-field Energy Treated Vitamin D3inMG-63 Cell Line
  155. Biofield Energy Enriched Vitamin D3 versus Vitamin D3 in Preventing Fractures and Bone Loss
  156. Functional Modification of Bone Tissues After Treatment with the Biofield Energy Treated Vitamin D3 in Human Bone Osteosarcoma Cells (MG-63)
  157. Role of Biofield Energy Treated Vitamin D3 in Human Bone Osteosarcoma Cells (MG-63): A Multidisciplinary Aspect on Bone Health
  158. Vitamin D3 and Consciousness Energy Healing TreatmentModality on Human Osteoblast Cells
  159. The Bone Regenerative Effects of the Biofield Energy Treated Vitamin D3 in Human Bone Osteosarcoma Cells (MG-63)
  160. Biofield Energy Healing Based Vitamin D3: An Improved Overall Bone Health Activity in MG-63 Cell Line
  161. Influence of the Biofield Energy Treated Vitamin D<sub>3</sub> on Human Osteoblast-Like Cells
  162. Effect of Biofield EnergyTreated Vitamin D3 on the Proliferation of Osteoblast-Like MG-63 Human Osteosarcoma Cells in vitro
  163. Biofield Energy Based Vitamin D<sub>3</sub> Stimulates <i>In vitro</i> Osteoblasts Differentiation in MG-63 Cell line
  164. An <i>In vitro</i> Experiment on Bone Growth and Differentiation in Human Bone Osteosarcoma Cells (MG-63): Impact of Biofield Energy Treated Vitamin D<sub>3</sub>
  165. Assessment of Bone Health After Treatment with the Consciousness Energy Healing Treated Vitamin D<sub>3</sub> in Human Bone Osteosarcoma Cells (MG-63)
  166. Biofield Energy Enriched Vitamin D<sub>3</sub>: A New Horizons for Development of Bone Health Using MG-63 Cells
  167. Regulation of Bone Health Parameters After Treatment with Biofield Energy Healing Based Vitamin D<sub>3</sub> on Human Osteoblast Cell Line (MG-63)
  168. <i>In vitro</i> Study on Human Bone Osteosarcoma Cells (MG-63): Role of Biofield Energy Treated Vitamin D<sub>3</sub>
  169. Biofield Energy Treated Vitamin D<sub>3</sub>: Therapeutic Implication on Bone Health Using Osteoblasts Cells
  170. The Influence of Biofield Energy Treated Vitamin D<sub>3</sub> on Bone Health and Its Health Consequences in MG-63 Cell-Line
  171. Effect of Biofield Energized Vitamin D<sub>3</sub> on Bone Health in MG-63 Cell-Line
  172. Regulation of Bone Health Parameters in MG-63 Cell Line After Treatment with Biofield Energy Treated Vitamin D<sub>3</sub>
  173. The Effect of Vitamin D<sub>3</sub> on Bone Mineralization: Influence of Consciousness Energy Healing Treatment
  174. Evaluation of Biofield Energy Treated Vitamin D<sub>3</sub> on Bone Health Parameters in Human Bone Osteosarcoma Cells (MG-63)
  175. Influence of Biofield Treated Vitamin D<sub>3</sub> on Proliferation, Differentiation, and Maturation of Bone-Related Parameters in MG-63 Cell-Line
  176. A Perspective of Bone Health Study: Impact of Biofield Energy Treated Vitamin D<sub>3</sub>
  177. Influenced of Biofield Energy Healing Treatment on Vitamin D<sub>3</sub> for the Assessment of Bone Health Parameters in MG-63 cells
  178. Evaluation of Biofield Energy Treated Vitamin D<sup>3</sup> in Human Osteoblasts Cells
  179. Exploring the Effects of Biofield Energy Treated Vitamin D<sup>3</sup> on Bone Health Parameters in MG-63 Cell Line
  180. The Potential Benefits of Biofield Energy Treated Vitamin D<sub>3</sub> on Bone Mineralization in Human Bone Osteosarcoma Cells (MG-63)
  181. Improved Metabolism of Vitamin D<sub>3</sub> in Human Osteoblasts Cells After Biofield Energy Healing Treatment
  182. An Alternative Approach for the Management of Bone Health: Role of Biofield Energy Healing Treated Vitamin D<sub>3</sub>
  183. Effects of Vitamin D<sub>3</sub> on the Proliferation and Mineralization of Human Osteoblast-Like Cells: Implications of Biofield Energy Healing Treatment
  184. Impact of Biofield Energy Healing Treated Vitamin D<sub>3</sub> on Human Osteoblast Cell Line (MG-63) for Bone Health
  185. Role of Vitamin D<sub>3</sub> on Alkaline Phosphatase, Collagen, and Bone Mineralization: Impact of Biofield Energy Healing Treatment
  186. Biofield Energy Treated Vitamin D<sub>3</sub>: Direct Effect on Bone Health Using Human Osteoblast-Like Cells
  187. <i>In Vitro</i> Effects of Biofield Energy Treated Vitamin D<sub>3</sub> Supplementation on Bone Formation by Osteoblasts Cells
  188. Energy of Consciousness Healing on Growth and Yield of the Plant Stem Cells Culture
  189. Evaluation of the Effect of Consciousness Energy Healing Treatment on Physicochemical and Thermal Properties of Flutamide
  190. Influence of the Biofield Energy Healing Treatment on the Physicochemical and Thermal Properties of Metronidazole
  191. Physicochemical and Thermal Properties of Consciousness Energy Healing Treated Hydroxypropyl -Cyclodextrin
  192. Evaluation of the Effect ofBiofield Energy Treatment on Physicochemical and Thermal Properties of Hydroxypropyl β-Cyclodextrin
  193. Effect of Biofield Energy Treatment on Bone Cell Proliferation and Differentiation for the Assessment of its Potential to Improve Bone Health
  194. Physicochemical and Spectroscopic Characterization of Biofield TreatedButylated Hydroxytoluene
  195. Effect of Biofield Energy Treated Cell Growth Medium on Human Fibroblast Cell Growth for Assessment of Skin Health Promotion Potential
  196. Evaluation of Bone Mineral Density and Biochemical Parameters of Bone Metabolism after Treatment with Biofield Energy Treated Vitamin D3 in MG-63 Cells
  197. An Alternative Therapeutic Approach on Bone Cells Differentiation after Administration of Biofield Energy Treated Vitamin D3 in MG-63 Cell line
  198. Spectral, and Thermal Properties of Sodium Selenate Treated with the Energy of Consciousness
  199. Consciousness Healing Treatment on the Physical, Structural, and Thermal Properties of Zinc Chloride
  200. Physicochemical, Thermal, Structural, and Behavioral Properties of Magnesium Gluconate
  201. Energy Healing Treatment on the Physical, Spectral, and Thermal Properties of Zinc Chloride
  202. Isotopic Abundance Ratio of Magnesium Gluconate Using LC-MS and NMR Spectroscopy
  203. Structure and Isotopic Abundance Ratio of Magnesium Gluconate Using LC-MS and NMR Spectroscopy
  204. Withania somnifera (Ashwagandha) Root Extract Treated with the Energy of Consciousness
  205. Properties of Sodium Selenate Treated with the Energy of Consciousness (The Trivedi Effect®)
  206. Properties and Isotopic Abundance Ratio of Biofield Energy Treated Magnesium Gluconate
  207. Evaluation of Isotopic Abundance Ratio and Structural Properties of Magnesium Gluconate
  208. Evaluation of Physicochemical, Spectral, Thermal and Behavioral Properties of Sodium Selenate
  209. Evaluation of the Energy of Consciousness Healing Treated Withania somnifera Root Extract
  210. Magnesium Gluconate Treated with the Energy of Consciousness Using LC-MS and NMR Spectroscopy
  211. Withania Somnifera (Ashwagandha) Root Extract Using LC-MS, GC-MS, and NMR Spectroscopy
  212. Physical, Spectroscopic, Thermal and Behavioral Properties of Ashwagandha Root Extract
  213. Physicochemical, Spectral, Thermal and Behavioral Properties of Sodium Selenate
  214. Consciousness Energy Healing Treatment on Withania somnifera Root Extract
  215. Evaluation of the Physicochemical, Structural, Thermal, and Behavioral Properties of Zinc Chloride
  216. Evaluation of Skin Protective Effect Using in Vitro Cell Line Models of Biofield
  217. Skin Nourishing Effects of Biofield Energy Healing Treatment Based Herbomineral Formulation
  218. Skin Protective Activity of Consciousness Energy Healing Treatment Based Herbomineral Formulation
  219. The Study of Biofield Energy Treatment Based Herbomineral Formulation in Skin Health and Function
  220. Use of Consciousness Energy Healing Based Herbomineral Formulation for Skin Anti-Aging Strategies
  221. Overall Skin Health Potential of the Biofield Energy Healing Based Herbomineral Formulation
  222. Energy Healing Treatment on Herbomineral Formulation in Different Skin Health Parameters
  223. Biofield Energy Healing Based Herbomineral Formulation: An Emerging Frontier in Cosmetic Medicine
  224. Thermal and Behavioral Properties of the Biofield Energy Healing Treated Sodium Selenate
  225. Physicochemical, Thermal and Behavioral Properties of Ashwagandha Root Extract
  226. Structural Characterization and Isotopic Abundance Ratio Analysis of Magnesium Gluconate
  227. Healing Treatment on Physical, Structural, Thermal, and Behavioral Properties of Zinc Chloride
  228. Consciousness Healing Treated Withania Somnifera Root Extract Using LC-MS, GC-MS, and NMR
  229. Withania somnifera Root Extract Using GC-MS and Nuclear Magnetic Resonance Spectroscopy
  230. Physicochemical, Thermal, Structural, and Behavioral Properties Analysis in Magnesium Gluconate
  231. Physicochemical, Thermal, Structural, and Behavioral Properties of Magnesium Gluconate
  232. Solid State Characterization of Withania somnifera (Ashwagandha) Root Extract
  233. Energy Healing Treatment Based Herbomineral Formulation Against Various Skin Health Parameters
  234. Skin Photo-Protective and Anti-ageing Activity of Consciousness Energy Healing Treatment
  235. An in Vitro Study of Biofield Energy Healing Based Herbomineral Formulation for Skin Protection
  236. Immunomodulatory Response of Herbomineral Formulation in Male Sprague Dawley Rats
  237. Novel Herbomineral Formulation After Oral Administration in Male Sprague Dawley Rats
  238. Characterization of the Consciousness Energy Healing Treated Withania somnifera Root Extract
  239. Analysis of Withania somnifera Root Extract After Treatment with the Energy of Consciousness
  240. Differential Regulation of Immune Biomarkers by the The Trivedi Effect® on Herbomineral Formulation
  241. Immunopotentiating Impact of The Trivedi Effect® on Herbomineral Formulation Oral Administration
  242. Evaluation of the Physico-chemical, Thermal and Behavioral Properties of Ashwagandha Root Extract
  243. Impact of Trivedi Effect® on Physicochemical, Thermal, Properties of Magnesium Gluconate
  244. Evaluation of Immunomodulatory Properties After Oral Administration of Biofield Energy Treated Test Formulation in <i>Sprague Dawley</i> Rats: Influence of the Trivedi Effect<sup>®</sup>
  245. Evaluation of the Effects of Biofield Energy Healing Based Herbomineral Formulation on Various Biomarkers in Male <i>Sprague Dawley</i> Rats: Potential Role of the Trivedi Effect<sup>®</sup>
  246. Characterization of Physicochemical, Thermal, Structural, and Behavioral Properties of Magnesium Gluconate After Treatment with the Energy of Consciousness
  247. Evaluation of Immune Biomarkers After Oral Administration of the Novel Herbomineral Formulation Treated with The Trivedi Effect<sup>®</sup> - Biofield Energy Healing in Male <i>Sprague Dawley</i> Rats
  248. Immunomodulatory Activity of Biofield Energy Healing Based Herbomineral Formulation in <i>Sprague Dawley</i> Rats: Evidence for Humoral and Cell-Mediated Responses
  249. An Investigation of The Trivedi Effect<sup>®</sup>-Energy of Consciousness Healing Treatment to Modulate the Immunomodulatory Effect of Herbomineral Formulation in Male <i>Sprague Dawley</i> Rats
  250. Assessment of Consciousness Energy Healing Treatment on Immune Biomarkers After Oral Administration of Herbomineral Formulation in <i>Sprague Dawley</i> Male Rats
  251. Evaluation of Immune Biomarkers After Oral Administration of Biofield Energy Healing Based Herbomineral Formulation in Male <i>Sprague Dawley</i> Rats
  252. Evaluation of Immunomodulatory Parameters in Female <i>Sprague Dawley</i> Rats after Oral Administration of the Biofield Energy Healing Treated Herbomineral Formulation
  253. Impact of Biofield Treated Formulation on Immune Biomarkers of Female Sprague Dawley Rats
  254. Investigation of Immune Biomarkers Regulation by Biofield Energy Healing (The Trivedi Effect<sup>®</sup>) Based Herbomineral Formulation in Male <i>Sprague Dawley</i> Rats
  255. Modulation of Immune Biomarkers by Biofield Energy Healing Based Herbomineral Formulation in Male <i>Sprague Dawley</i> Rat: Potential Role of Energy of Consciousness
  256. Effect of Biofield Energy Healing (The Trivedi Effect<sup>®</sup>) Based Novel Herbomineral Formulation on Immune Biomarkers After Oral Administration in Female <i>Sprague Dawley</i> Rats
  257. Immunomodulatory Potential of New Classical Herbomineral Formulation in Experimental Animals: Impact of Biofield Energy Healing Treatment
  258. Assessment of Immunomodulatory Activity of the Biofield Energy Treated Novel Herbomineral Formulation After Oral Administration in Female <i>Sprague Dawley</i> Rats
  259. Characterization of the Physicochemical, Structural, and Thermal Properties of Zinc Chloride After the Consciousness Energy Healing Treatment
  260. Implication of Biofield Energy Healing Based Vitamin D3 on Osteoblastic Differentiation
  261. Improved Bone Health Parameters After Treatment with Consciousness Energy Treated Vitamin D3
  262. Characterization of Physical, Thermal and Spectroscopic Properties of Biofield Treated Ortho-Toluic Acid
  263. Biochemical Reactions, and Genotypic Pattern of Biofield Treated Pseudomonas aeruginosa
  264. Thermal, Spectroscopic and Chemical Characterization of Biofield Energy Treated Anisole
  265. Biofield Energy Treated Nitrophenol Derivatives Using Gas Chromatography-Mass Spectrometry
  266. Physicochemical Characterization of Biofield Energy Treated Hi VegTM Acid Hydrolysate
  267. 1,2,3-Trimethoxybenzene (TMB) After Biofield Energy Treatment (The Trivedi Effect®) Using GC-MS
  268. Biofield Energy Treated Resorcinol Using Gas Chromatography-Mass Spectrometry Technique
  269. Isotopic Abundance of 2H, 13C, 18O, and 37Cl in Biofield Energy Treated Dichlorophenol Isomers
  270. Isotopic Abundance Ratio Analysis of Biofield Energy Treated Indole Using GC-MS
  271. 13C/12C or 2H/1H and 18O/16O in Biofield Energy Treated 1-Chloro-3-Nitrobenzene (3-CNB) Using GC-MS
  272. Isotopic Abundance of 13C, 2H, and 18O in Biofield Energy Treated p-tertiary Butylphenol (PTBP)
  273. Isotopic Abundance Ratio Analysis of Biofield Energy Treated Methyl-2-napthylether (Nerolin)
  274. Biofield Energy Treated 1,4-Dichlorobenzene Using Gas Chromatography-Mass Spectrometry (GC-MS)
  275. Biofield Energy Healing (The Trivedi Effect®) Based Herbomineral Formulation in Mouse Splenocytes
  276. Evaluation Mouse Splenocytes After Co-Incubation with the Biofield Energy Treated Formulation
  277. Mouse Splenocyte Cells After Incubation with Biofield Energy Healing Based Herbomineral Formulation
  278. Impact of the Trivedi Effect Herbomineral Formulation on Pro-inflammatory Cytokines Expression
  279. Pro-Inflammatory Cytokines Expression in Murine Dendritic and Splenocyte Cells
  280. Mouse Splenocytes After Incubation with Biofield Treated Herbomineral Formulation
  281. Mouse Dendritic and Splenocyte Cells for Modulation of Pro-inflammatory Cytokines
  282. Fourier Transform Infrared and Ultraviolet-Visible Spectroscopic Characterization of Ammonium Acetate and Ammonium Chloride: An Impact of Biofield Treatment
  283. Characterization of Physical, Thermal and Structural Properties of Chromium (VI) Oxide Powder: Impact of Biofield Treatment
  284. Characterization of Physical, Spectral and Thermal Properties of Biofield Treated 1,2,4-Triazole
  285. Antibiogram Typing and Biochemical Characterization of Klebsiella pneumoniae after Biofield Treatment
  286. Physical, Thermal and Spectroscopic Characterization of m-Toluic Acid: an Impact of Biofield Treatment
  287. Fourier Transform Infrared and Ultraviolet-Visible Spectroscopic Characterization of Biofield Treated Salicylic Acid and Sparfloxacin
  288. Physical and Structural Characterization of Biofield Treated Imidazole Derivatives
  289. Evaluation of Physical, Thermal and Spectroscopic Properties of Biofield Treated p-Hydroxyacetophenone
  290. Characterization of Physico-Chemical and Spectroscopic Properties of Biofield Energy Treated 4-Bromoacetophenone
  291. Physicochemical and Spectroscopic Characterization of Biofield Treated Triphenyl Phosphate
  292. Physical and Structural Characterization of Biofield Energy Treated Carbazole
  293. Evaluation of Biofield Treatment on Atomic and Thermal Properties of Ethanol
  294. Characterisation of Physical, Spectral and Thermal Properties of Biofield treated Resorcinol
  295. Physicochemical and Atomic Characterization of Silver Powder after Biofield Treatment
  296. Spectroscopic Characterization of Disodium Hydrogen Orthophosphate and Sodium Nitrate after Biofield Treatment
  297. Characterization of Physical and Structural Properties of Aluminium Carbide Powder: Impact of Biofield Treatment
  298. Phenotyping and 16S rDNA Analysis after Biofield Treatment on Citrobacter braakii: A Urinary Pathogen
  299. Physical, Thermal, and Spectroscopic Characterization of Biofield Energy Treated Methyl-2-Naphthyl Ether
  300. Antimicrobial Sensitivity, Biochemical Characteristics and Biotyping of Staphylococcus saprophyticus: An Impact of Biofield Energy Treatment
  301. Physical, Thermal and Spectral Properties of Biofield Treated 1,2,3-Trimethoxybenzene
  302. Effect of Biofield Energy Treatment on Streptococcus group B: A Postpartum Pathogen
  303. Physical, Thermal and Spectroscopic Characterization of Biofield Treated p-Chloro-m-cresoln
  304. Characterization of Physical, Thermal and Spectral Properties of Biofield Treated 2, 6-Diaminopyridine
  305. Characterization of Physical, Thermal and Spectral Properties of Biofield Treated O-Aminophenol
  306. Characterization of Physicochemical and Thermal Properties of Chitosan and Sodium Alginate after Biofield Treatment
  307. Biofield Energy Treatment: A Potential Strategy for Modulating Physical, Thermal and Spectral Properties of 3-Chloro-4-fluoroaniline
  308. The Potential Impact of Biofield Energy Treatment on the Physical and Thermal Properties of Silver Oxide Powder
  309. Physical and Thermal Properties of O-Nitrophenol, M-Nitrophenol and P-Tertiary Butyl Phenol
  310. Antibiogram Pattern of Shigella flexneri: Effect of BioField Treatment
  311. Physical, Thermal and Spectral Properties of Biofield Energy Treated 2,4-Dihydroxybenzophenone
  312. Characterization of Physical, Thermal and Spectroscopic Properties of Biofield Energy Treated p-Phenylenediamine and p-Toluidine
  313. Characterization of Phenotype and Genotype of Biofield Treated Enterobacter aerogenes
  314. Evaluation of Antibiogram, Genotype and Phylogenetic Analysis of Biofield Treated Nocardia otitidis
  315. Potential Impact of BioField Treatment on Atomic and Physical Characteristics of Magnesium
  316. Evaluation of Thermal and Physical Properties of Magnesium Nitride Powder: Impact of Biofield Energy Treatment
  317. Influence of Biofield Treatment on Physical and Structural Characteristics of Barium Oxide and Zinc Sulfide
  318. Antibiogram and Genotypic Analysis using 16S rDNA after Biofield Treatment on Morganella morganii
  319. Investigation of Biofield Treatment on Antimicrobial Susceptibility, Biochemical Reaction Pattern and Biotyping of Enteropathogenic Multidrug-Resistant Escherichia coli Isolates
  320. Isotopic Abundance Analysis of Biofield Treated Benzene, Toluene and p-Xylene Using Gas Chromatography-Mass Spectrometry (GC-MS)
  321. Assessment of Antibiogram of Multidrug-Resistant Isolates of Enterobacter aerogenes after Biofield Energy Treatment
  322. Characterization of Biofield Energy Treated 3-Chloronitrobenzene: Physical, Thermal, and Spectroscopic Studies
  323. Impact of Biofield Energy Treatment on Soil Fertility
  324. Influence of Biofield Energy Treatment on Isotopic Abundance Ratio in Aniline Derivatives
  325. Studies on Physicochemical Properties of Biofield Treated 2,4-Dichlorophenol
  326. Physical, Thermal, and Spectroscopic Characterization of Biofield Energy Treated Potato Micropropagation Medium
  327. Evaluation of Biofield Treated Peptone And Malmgren Modified Terrestrial Orchid Medium
  328. Physical, Thermal and Spectral Properties of Biofield Treated 3-Nitroacetophenone
  329. Thermal, Spectroscopic and Chromatographic Characterization of Biofield Energy Treated Benzophenone
  330. Characterization of Physical, Thermal and Spectral Properties of Biofield Treated 2-Aminopyridine
  331. Characterization of Physical, Spectroscopic and Thermal Properties of Biofield Treated Biphenyl
  332. Characterization of Physical, Thermal and Spectral Properties of Biofield Treated 2,6-Dichlorophenol
  333. Physicochemical and Spectral Characterization of Biofield Energy Treated 4-Methylbenzoic Acid
  334. Chromatographic, Spectroscopic, and Thermal Characterization of Biofield Energy Treated N,N-Dimethylformamide
  335. Physicochemical Characterization of Biofield Energy Treated Calcium Carbonate Powder
  336. Molecular Analysis of Biofield Treated Eggplant and Watermelon Crops
  337. Physicochemical and Spectroscopic Characterization of Biofield Energy Treated p-Anisidine
  338. Characterization of Physical and Thermal Properties of Biofield Treated Neopentyl glycol
  339. Physical, Thermal and Spectral Parameters of Biofield Energy Treated Methylsulfonylmethane
  340. Antibiogram Typing of Biofield Treated Multidrug Resistant Strains of Staphylococcus Species
  341. Analysis of Physical, Thermal, and Structural Properties of Biofield Energy Treated Molybdenum Dioxide
  342. Physical and Structural Properties of Calcium Carbide and Praseodymium Oxide
  343. Physicochemical and Spectroscopic Characteristics of Biofield Treated p-Chlorobenzophenone
  344. Characterization of Physical, Thermal and Spectral Properties of Biofield Treated Date Palm Callus Initiation Medium
  345. Biofield Energy Treatment on Physical and Thermal Characteristics of Selenium Powder
  346. Morphological Characterization, Quality, Yield & DNA Fingerprinting of Energy Treated Alphonso Mango
  347. Escherichia coli for Antimicrobial Susceptibility, Biochemical Reaction and Biotyping
  348. Evaluation of Isotopic Abundance Ratio in Naphthalene Derivatives After Biofield Energy Treatment
  349. Improved Susceptibility Pattern of Antimicrobials Using Vital Energy Treatment on Shigella sonnei
  350. Biochemical Differentiation & Molecular Characterization of Biofield Treated Vibrio parahaemolyticus
  351. Physical, Thermal and Spectroscopical Characterization of Biofield Treated Triphenylmethane: An Impact of Biofield Treatment
  352. Experimental Investigation on Physical, Thermal and Spectroscopic Properties of 2-Chlorobenzonitrile: Impact of Biofield Treatment
  353. Characterization of Biofield Energy Treated Murashige and Skoog Plant Cell Culture Media
  354. Physicochemical and Spectroscopic Characterization of Yeast Extract Powder After the Biofield Energy Treatment
  355. Physical, Spectroscopic and Thermal Characterization of Biofield Treated Fish Peptone
  356. Physicochemical and Spectroscopic Properties of Biofield Energy Treated Protose
  357. Physicochemical and Spectroscopic Characterization of Biofield Energy Treated Gerbera Multiplication Medium
  358. Biofield Treated Phosphate Buffer Saline and Hanks Balanced Salt Medium
  359. Characterization of Physicochemical and Spectroscopic Properties of Biofield Energy Treated Bio Peptone
  360. Spectral and Thermal Properties of Biofield Energy Treated Cotton
  361. Effect of Biofield Treated Energized Water on the Growth and Health Status in Chicken
  362. Characterization of Atomic and Physical Properties of Biofield Energy Treated Manganese Sulfide Powder
  363. Assessment of Antibiogram of Biofield Energy Treated Serratia marcescens
  364. Biofield Treatment on Viral Load Against Human Immunodeficiency-1 and Cytomegalo Viruses
  365. Antibiogram, Biochemical Reactions and Biotyping of Biofield Treated Providencia rettgeri
  366. Isotopic Abundance Analysis of Biofield Treated Benzene, Toluene and p-Xylene Using GC-MS
  367. Phenotyping and Genotyping Characterization of Proteus vulgaris After Biofield Treatment
  368. Plant Growth Regulator, Immunity and DNA Fingerprinting of Biofield Energy Treated Mustard Seeds
  369. Agronomic Characteristics, Growth Analysis, and Yield Response of Biofield Treated Mustard, Cowpea, Horse Gram, and Groundnuts
  370. Physical, Thermal and Spectroscopic Studies of Biofield Treated p-Chlorobenzonitrile
  371. Effect of Biofield Treatment on Physical, Thermal, and Spectral Properties of SFRE 199-1 Mammalian Cell Culture Medium
  372. Biochemical Marker – Glutathione and DNA Fingerprinting of Biofield Energy Treated Oryza sativa
  373. Antibiogram of Biofield-Treated Shigella boydii: Global Burden of Infections
  374. Morphological and Molecular Analysis Using RAPD in Biofield Treated Sponge and Bitter Gourd
  375. Antibiogram, Biochemical Reactions and Genotyping Characterization of Biofield Treated <i>Staphylococcus aureus</i>
  376. Isotopic Abundance of 13C, 2H, or 15N in Biofield Energy Treated Aminopyridine Derivatives
  377. Vegetative Growth Parameters in Biofield Treated Bottle Gourd (Lagenaria siceraria) & Okra
  378. Genetic Diversity Using SSR Markers & Growth Regulator Response in Biofield Treated Cotton
  379. Ratio of 13C, 2H, and 18O in Biofield Energy Treated Ortho and Meta Toluic Acid Isomers
  380. Plant Growth, Yield and Yield Attributes of Biofield Energy Treated Mustard and Chick Pea Seeds
  381. Antimicrobial Susceptibility of Proteus mirabilis: Impact of Biofield Energy Treatment
  382. Bacterial Identification Using 16S rDNA Gene Sequencing and Antibiogram Analysis on Biofield Treated Pseudomonas fluorescens
  383. Impact of Biofield Treatment on Spectroscopic and Physicochemical Properties of p-Nitroaniline
  384. Physicochemical and Spectroscopic Characterization of p-Chlorobenzaldehyde: An Impact of Biofield Energy Treatment
  385. Evaluation of Atomic, Physical and Thermal Properties of Tellurium Powder: Impact of Biofield Energy Treatment
  386. Antibiogram of Multidrug-Resistant Isolates of Pseudomonas aeruginosa after Biofield Treatment
  387. Characterization of Antimicrobial Susceptibility Profile of Biofield Treated Multidrug-resistant Klebsiella oxytoca
  388. Phenotyping and 16S rDNA Analysis after Biofield Treatment on Citrobacter braakii
  389. Antimicrobial Susceptibility, Biochemical Characterization and Molecular Typing of Biofield Treated Klebsiella pneumoniae
  390. Modification of Physical and Thermal Properties of Gluten Hydrolysate and Ipomoea Macroelements
  391. Investigation of Isotopic Abundance Ratio of Biofield Treated Phenol Derivatives Using Gas Chromatography-Mass Spectrometry
  392. Physical, Atomic and Thermal Properties of Biofield Treated Lithium Powder
  393. Potential Impact of Biofield Energy Treatment on the Atomic, Physical and Thermal Properties Indium Powder
  394. Physical, Spectroscopic and Thermal Characterization of Biofield treated Myristic acid
  395. Physical, Thermal and Spectroscopic Studies on Biofield Treated p-Dichlorobenzene
  396. Antimicrobial Susceptibility Pattern, Biochemical Characteristics and Biotyping of Salmonella paratyphi A: An Impact of Biofield Treatment
  397. Spectroscopic Characterization of Disulfiram and Nicotinic Acid after Biofield Treatment
  398. Biofield Treatment: A Potential Strategy for Modification of Physical and Thermal Properties of Indole
  399. In Vitro Evaluation of Antifungal Sensitivity Assay of Biofield Energy Treated Fungi